Maribel Almonte (France)
International Agency for Research on Cancer Prevention and Implementation Group
Presenter of 2 Presentations
Validation of assays used for screening or triage in the Estampa study (ID 1572)
Session Time
10:40 - 11:45
Session Type
Dedicated Symposium
Lecture Time
11:28 - 11:43
[{"name":"Validation of assays used for screening or triage in the Estampa study \u003Csmall\u003E(ID 1572)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1572,"presentation":"Validation of assays used for screening or triage in the Estampa study \u003Csmall\u003E(ID 1572)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Maribel Almonte (France)","photo":""},"playlist":[{"name":"Validation of assays used for screening or triage in the Estampa study","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/DA4D5473.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22UU0t7"}
[session]
[presentation]
[presenter]
PERFORMANCE OF A NEW ONCOPROTEIN E6/E7 TEST TO DETECT CIN3+ WITHIN THE ESTAMPA STUDY (ID 1290)
Session Time
15:00 - 15:50
Session Type
Clinical Science Oral Session
Lecture Time
15:12 - 15:24
[{"name":"PERFORMANCE OF A NEW ONCOPROTEIN E6\/E7 TEST TO DETECT CIN3+ WITHIN THE ESTAMPA STUDY \u003Csmall\u003E(ID 1290)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1290,"presentation":"PERFORMANCE OF A NEW ONCOPROTEIN E6\/E7 TEST TO DETECT CIN3+ WITHIN THE ESTAMPA STUDY \u003Csmall\u003E(ID 1290)\u003C\/small\u003E","session":"Oral Session 2: Cervical\/Anal Screening and Management","presenter":"Maribel Almonte (France)","photo":""},"playlist":[{"name":"Maribel Almonte - IPVC20 - 1290 - PERFORMANCE OF A NEW ONCOPROTEIN E6E7 TEST TO DETECT CIN3 WITHIN T","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/73\/Maribel Almonte - IPVC20 - 1290 - PERFORMANCE OF A NEW ONCOPROTEIN E6E7 TEST TO DETECT CIN3 WITHIN THE ESTAMPA STUDy -2-.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/73\/Maribel Almonte - IPVC20 - 1290 - PERFORMANCE OF A NEW ONCOPROTEIN E6E7 TEST TO DETECT CIN3 WITHIN THE ESTAMPA STUDy -2-.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/73\/B41CAFD9.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/73\/Maribel Almonte - IPVC20 - 1290 - PERFORMANCE OF A NEW ONCOPROTEIN E6E7 TEST TO DETECT CIN3 WITHIN THE ESTAMPA STUDy -2-.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22UU0of"}
[session]
[presentation]
[presenter]
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
12:20 - 14:20
[{"name":"ADVANCING CERVICAL CANCER PREVENTION: THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES FOR CERVICAL CANCER SCREENING IN LOW AND MIDDLE INCOME COUNTRIES \u003Csmall\u003E(ID 1188)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1188,"presentation":"ADVANCING CERVICAL CANCER PREVENTION: THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES FOR CERVICAL CANCER SCREENING IN LOW AND MIDDLE INCOME COUNTRIES \u003Csmall\u003E(ID 1188)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"VERONICA B. Reis (United States of America)","photo":""},"playlist":[{"name":"ADVANCING CERVICAL CANCER PREVENTION: THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Veronica Reis IPVC20 1188 ADVANCING CERVICAL CANCER PREVENTION THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES FOR CERVICAL CANCER SCREENING IN LOW AND MIDDLE INCOME C.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/Veronica Reis IPVC20 1188 ADVANCING CERVICAL CANCER PREVENTION THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES FOR CERVICAL CANCER SCREENING IN LOW AND MIDDLE INCOME C.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/D8F3D53D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Veronica Reis IPVC20 1188 ADVANCING CERVICAL CANCER PREVENTION THE EFFORT TO INTRODUCE HPV TESTING OF SELF-COLLECTED SAMPLES FOR CERVICAL CANCER SCREENING IN LOW AND MIDDLE INCOME C.vtt"}]},{"name":"HPV TESTING, TRIAGE AND TREATMENT FOR CERVICAL PRECANCER IN NICARAGUA WITHIN THE PUBLIC SECTOR HEALTH SYSTEM \u003Csmall\u003E(ID 1160)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1160,"presentation":"HPV TESTING, TRIAGE AND TREATMENT FOR CERVICAL PRECANCER IN NICARAGUA WITHIN THE PUBLIC SECTOR HEALTH SYSTEM \u003Csmall\u003E(ID 1160)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Francesca Holme (United States of America)","photo":""},"playlist":[{"name":"HPV TESTING TRIAGE AND TREATMENT FOR CERVICAL PRECANCER IN NICARAGUA WITHIN THE PUBLIC SECTOR HEALTH","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Francesca Holme Kerry Thomson - IPVC20 - 1160.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/Francesca Holme Kerry Thomson - IPVC20 - 1160.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/E240CEA4.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Francesca Holme Kerry Thomson - IPVC20 - 1160.vtt"}]},{"name":"UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VISUAL INSPECTION WITH ACETIC ACID: A CLUSTER RANDOMIZED TRIAL \u003Csmall\u003E(ID 246)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":246,"presentation":"UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VISUAL INSPECTION WITH ACETIC ACID: A CLUSTER RANDOMIZED TRIAL \u003Csmall\u003E(ID 246)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Muluken Gizaw (Ethiopia)","photo":""},"playlist":[{"name":"UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VIS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Muluken Gizaw - IPVC20 - 246 - UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VISUAL INSPECTION WITH ACETIC ACID A CLUSTER RANDOMIZED TRIAL.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/Muluken Gizaw - IPVC20 - 246 - UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VISUAL INSPECTION WITH ACETIC ACID A CLUSTER RANDOMIZED TRIAL.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/7F2C2161.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/Muluken Gizaw - IPVC20 - 246 - UPTAKE OF CERVICAL CANCER SCREENING IN ETHIOPIA BY SELF-SAMPLING FOR HPV DNA TESTING COMPARED TO VISUAL INSPECTION WITH ACETIC ACID A CLUSTER RANDOMIZED TRIAL.vtt"}]},{"name":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENTE NORTHERN CALIFORNIA \u003Csmall\u003E(ID 1342)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1342,"presentation":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENTE NORTHERN CALIFORNIA \u003Csmall\u003E(ID 1342)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Julia C. Gage (United States of America)","photo":""},"playlist":[{"name":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/45A7A552.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.vtt"}]},{"name":"SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL \u003Csmall\u003E(ID 823)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":823,"presentation":"SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL \u003Csmall\u003E(ID 823)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Bo T Hansen (Norway)","photo":""},"playlist":[{"name":"SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY A PRAGMATIC RANDO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/NEW_Bo Terning Hansen IPVC20 823 SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY A PRAGMATIC RANDOMIZED CONTROLLED TRIAL.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/NEW_Bo Terning Hansen IPVC20 823 SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY A PRAGMATIC RANDOMIZED CONTROLLED TRIAL.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/AB7FDC9D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/NEW_Bo Terning Hansen IPVC20 823 SELF-SAMPLING AMONG LONG-TERM NON-ATTENDERS TO CERVICAL CANCER SCREENING IN NORWAY A PRAGMATIC RANDOMIZED CONTROLLED TRIAL.vtt"}]},{"name":"EFFECTIVENESS OF A MULTI-COMPONENT MHEALTH INTERVENTION FOR TRIAGE AFTER HPV SELF-COLLECTION: PRELIMINARY RESULTS OF THE ATICA CLUSTER RANDOMIZED TRIAL \u003Csmall\u003E(ID 760)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":760,"presentation":"EFFECTIVENESS OF A MULTI-COMPONENT MHEALTH INTERVENTION FOR TRIAGE AFTER HPV SELF-COLLECTION: PRELIMINARY RESULTS OF THE ATICA CLUSTER RANDOMIZED TRIAL \u003Csmall\u003E(ID 760)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Silvina Arrossi (Argentina)","photo":""},"playlist":[{"name":"EFFECTIVENESS OF A MULTI-COMPONENT MHEALTH INTERVENTION FOR TRIAGE AFTER HPV SELF-COLLECTION: PRELIM","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200618-115201_Silvina-Ar_1440x900.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200618-115201_Silvina-Ar_1440x900.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/803AC2FF.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200618-115201_Silvina-Ar_1440x900.vtt"}]},{"name":"PAVING THE WAY TO NEW LOW COST METHODS IN CERVICAL SCREENING: SELF-SAMPLED HPV TESTING AND DEVELOPMENT OF AUTOMATED VISUAL EVALUATION OF SMART PHONE IMAGES \u003Csmall\u003E(ID 153)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":153,"presentation":"PAVING THE WAY TO NEW LOW COST METHODS IN CERVICAL SCREENING: SELF-SAMPLED HPV TESTING AND DEVELOPMENT OF AUTOMATED VISUAL EVALUATION OF SMART PHONE IMAGES \u003Csmall\u003E(ID 153)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Olusegun K. Ajenifuja (Nigeria)","photo":""},"playlist":[{"name":"PAVING THE WAY TO NEW LOW COST METHODS IN CERVICAL SCREENING: SELF-SAMPLED HPV TESTING AND DEVELOPME","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/IPVC PRESENTATION 153.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/IPVC PRESENTATION 153.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/B8C052DE.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/IPVC PRESENTATION 153.vtt"}]}]
{"type":2,"code":"7E32UU0L"}
[session]
[presentation]
[presenter]
